Association of immune checkpoint inhibitor with survival in patients with cancers with protein tyrosine phosphatase receptor T mutation

Detalles Bibliográficos
Autores principales: He, Zifan, Li, Anlin, Lin, Dagui, Gu, Yang, Chen, Yongjian, Ou, Qiyun, Li, Liren, Yao, Herui, Yu, Yunfang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Letter to Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591738/
https://www.ncbi.nlm.nih.gov/pubmed/33135355
http://dx.doi.org/10.1002/ctm2.214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591738/
https://www.ncbi.nlm.nih.gov/pubmed/33135355
http://dx.doi.org/10.1002/ctm2.214

Ejemplares similares